Please ensure Javascript is enabled for purposes of website accessibility

Why Invitae Stock Is Climbing Today

By Jason Hawthorne – Aug 4, 2021 at 12:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Accelerating growth is giving investors more confidence in the genetic testing company's long-term prospects.

What happened

Shares of Invitae (NVTA -1.42%) were up 9.4% as of 12:50 p.m. EDT Wednesday after the company delivered an upbeat earnings report and raised its guidance.

People gathered around a computer cheering.

Image source: Getty Images.

So what

The genetic testing company posted 152% year-over-year revenue growth in the second quarter and offered full-year guidance for revenues between $475 million and $500 million. Analysts had been projecting Invitae's 2021 top line would land at about $463 million.  The results were a welcome change from the previous several quarters, which featured pedestrian growth due to the impact of COVID-19.

Now what

Even after Wednesday's pop, the stock is down about 11% since early March, when Cathie Wood of ARK Investment Management called it one of the most under-appreciated companies in her ARK Genomic Revolution ETF. Part of that decline is attributable to dilution. Despite the company's impressive top-line growth this quarter, its revenue-per-share metric only climbed by 61% because there are 56% more shares outstanding than there were at this time last year. 

Invitae continues to burn cash, but it has $1.2 billion more on its balance sheet than it did a year ago thanks to an investment from Softbank Group (SFTB.Y -0.09%). It will need those funds, as its march toward positive cash generation has stalled in recent years.

Fundamental Chart Chart

Fundamental Chart data by YCharts

Management continues to see an addressable market for Invitae of more than $150 billion in the U.S. alone. If today's shareholders want to benefit from the company capturing a significant share of that market -- and turning those revenues into profits -- they're going to have to be patient. On Wednesday, it looked like more of them were comfortable with the idea of that wait.

Jason Hawthorne has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Invitae. The Motley Fool recommends Softbank Group. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invitae Stock Quote
Invitae
NVTA
$2.78 (-1.42%) $0.04
SoftBank Group Corp. Stock Quote
SoftBank Group Corp.
SFTB.Y
$21.82 (-0.09%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.